Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05788666 · ClinicalTrials.gov registry record · NA
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
A NA study of Ischemic Heart Disease, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05788666: Recruiting NA study of Ischemic Heart Disease, sponsored by NYU Langone Health.
NCT05788666 is a NA study of Ischemic Heart Disease that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 150 participants, below the 256-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05788666, a NA study of Ischemic Heart Disease, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Primary Outcome
Binary outcome; determined by review of patient electronic health record (EHR) data at Month 6.
Conditions Studied
Interventions
- PROCEDURE GeriKit Mobile Application
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT05788666 shows while recruiting
NCT05788666 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 256-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Ischemic Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which GeriKit Mobile Application is the first listed.
NCT05788666 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05788666 about?
NCT05788666 is a clinical study titled "Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease". This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
What is the current status of trial NCT05788666?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-01-18. Estimated completion is 2027-12-31.
What conditions does trial NCT05788666 study?
This clinical trial studies the following conditions: Ischemic Heart Disease.
What interventions are being tested in trial NCT05788666?
The interventions under investigation include: GeriKit Mobile Application (PROCEDURE).
Who is sponsoring clinical trial NCT05788666?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05788666 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05788666's enrollment target sits among peer trials
150 5th of 14 higher than 9 of 14 other Ischemic Heart Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Heart Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
ACTIVE NOT RECRUITING · NA
-
Chronic Total Occlusion Percutaneous Coronary Intervention Study
COMPLETED · NA
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI